Intriguingly, TP53, RYR1, and BAP1 mutations were noted to occur more in NR-HCC patients instead of LR-HCC patients (Figure 1C) though statistic difference in the two groups is not significant. This evidence concerns the gene TP53 and hepatocellular carcinoma.